{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T20:50:04Z","timestamp":1760215804278},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2015,3,5]],"date-time":"2015-03-05T00:00:00Z","timestamp":1425513600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1007\/s40618-015-0249-z","type":"journal-article","created":{"date-parts":[[2015,3,4]],"date-time":"2015-03-04T09:09:08Z","timestamp":1425460148000},"page":"711-716","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Mechanistic approach to the pathophysiology of target organ damage in hypertension from studies in a human model with characteristics opposite to hypertension: Bartter\u2019s and Gitelman\u2019s syndromes"],"prefix":"10.1007","volume":"38","author":[{"given":"L. A.","family":"Cal\u00f2","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Maiolino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,5]]},"reference":[{"key":"249_CR1","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1172\/JCI36703","volume":"119","author":"A Benigni","year":"2009","unstructured":"Benigni A, Corna D, Zoja C, Sonzogni A, Latini R, Salio M, Conti S, Rottoli D, Longaretti L, Cassis P, Morigi M, Coffman TM, Remuzzi G (2009) Disruption of the Ang II type 1 receptor promotes longevity in mice. J Clin Invest 119:524\u2013530","journal-title":"J Clin Invest"},{"key":"249_CR2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000076752","volume":"96","author":"M Naesens","year":"2004","unstructured":"Naesens M, Steels P, Verberckmoes R, Vanrenterghem Y, Kuypers D (2004) Bartter\u2019s and Gitelman\u2019s syndromes: from gene to clinic. Nephron Physiol 96:65\u201378","journal-title":"Nephron Physiol"},{"key":"249_CR3","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1159\/000188941","volume":"72","author":"L Cal\u00f2","year":"1996","unstructured":"Cal\u00f2 L, D\u2019Angelo A, Cantaro S, Rizzolo M, Favaro S, Antonello A, Borsatti A (1996) Intracellular calcium signalling and vascular reactivity in Bartter\u2019s syndrome. Nephron 72:570\u2013573","journal-title":"Nephron"},{"key":"249_CR4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/HJH.0b013e328332b738","volume":"28","author":"LA Cal\u00f2","year":"2010","unstructured":"Cal\u00f2 LA, Schiavo S, Davis PA, Pagnin E, Mormino P, D\u2019Angelo A, Pessina AC (2010) Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implications for hypertension. J Hypertens 28:111\u2013118","journal-title":"J Hypertens"},{"key":"249_CR5","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/sj.ki.5000253","volume":"69","author":"LA Cal\u00f2","year":"2006","unstructured":"Cal\u00f2 LA (2006) Vascular tone control in humans: insights from studies in Bartter\u2019s\/Gitelman\u2019s syndromes. Kidney Int 69:963\u2013966","journal-title":"Kidney Int"},{"key":"249_CR6","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1097\/HJH.0000000000000321","volume":"32","author":"LA Cal\u00f2","year":"2014","unstructured":"Cal\u00f2 LA, Davis PA, Rossi GP (2014) Understanding the mechanisms of angiotensin II signaling involved in hypertension and its long-term sequelae: insights from Bartter\u2019s and Gitelman\u2019s syndromes, human models of endogenous angiotensin II signaling antagonism. J Hypertens 32:2109\u20132119","journal-title":"J Hypertens"},{"key":"249_CR7","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1046\/j.1523-1755.2001.060003882.x","volume":"60","author":"LA Cal\u00f2","year":"2001","unstructured":"Cal\u00f2 LA, Ceolotto G, Milani M, Pagnin E, van den Heuvel LP, Sartori M, Davis PA, Costa R, Semplicini A (2001) Abnormalities of Gq-mediated cell signaling in Bartter and Gitelman syndromes. Kidney Int 60:882\u2013889","journal-title":"Kidney Int"},{"key":"249_CR8","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1210\/jc.2004-0498","volume":"89","author":"LA Cal\u00f2","year":"2004","unstructured":"Cal\u00f2 LA, Pagnin E, Davis PA, Sartori M, Ceolotto G, Pessina AC, Semplicini A (2004) Increased expression of regulator of G protein signaling-2 (RGS-2) in Bartter\u2019s\/Gitelman\u2019s syndrome. A role in the control of vascular tone and implication for hypertension. J Clin Endocrinol Metab 89:4153\u20134157","journal-title":"J Clin Endocrinol Metab"},{"key":"249_CR9","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1097\/HJH.0b013e3282f60d98","volume":"26","author":"LA Cal\u00f2","year":"2008","unstructured":"Cal\u00f2 LA, Pagnin E, Ceolotto G, Davis PA, Schiavo S, Papparella I, Semplicini A, Pessina AC (2008) Silencing regulator of G protein signaling-2 (RGS-2) increases angiotensin II signaling: insights into hypertension from findings in Bartter\u2019s\/Gitelman\u2019s syndromes. J Hypertens 26:938\u2013945","journal-title":"J Hypertens"},{"key":"249_CR10","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1042\/cs0720483","volume":"72","author":"F Di Virgilio","year":"1987","unstructured":"Di Virgilio F, Cal\u00f2 L, Cantaro S, Favaro S, Piccoli A, Borsatti A (1987) Resting and stimulated cytosolic free calcium levels in neutrophils from patients with Bartter\u2019s syndrome. Clin Sci 72:483\u2013488","journal-title":"Clin Sci"},{"key":"249_CR11","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1159\/000188941","volume":"72","author":"L Cal\u00f2","year":"1996","unstructured":"Cal\u00f2 L, D\u2019Angelo A, Cantaro S, Rizzolo M, Favaro S, Antonello A, Borsatti A (1996) Intracellular calcium signalling and vascular reactivity in Bartter\u2019s syndrome. Nephron 72:570\u2013573","journal-title":"Nephron"},{"key":"249_CR12","doi-asserted-by":"crossref","first-page":"C82","DOI":"10.1152\/ajpcell.00287.2006","volume":"92","author":"PK Mehta","year":"2007","unstructured":"Mehta PK, Griendling KK (2007) Angiotensin II cell signaling. Physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 92:C82\u2013C97","journal-title":"Am J Physiol Cell Physiol"},{"key":"249_CR13","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1161\/01.CIR.0000093661.90582.c4","volume":"108","author":"KK Griendling","year":"2003","unstructured":"Griendling KK, FitzGerald GA (2003) Oxidative stress and cardiovascular injury: part II: animal and human studies. Circulation 108:2034\u20132040","journal-title":"Circulation"},{"key":"249_CR14","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1093\/ndt\/gfg204","volume":"18","author":"LA Cal\u00f2","year":"2003","unstructured":"Cal\u00f2 LA, Pagnin E, Davis PA, Sartori M, Semplicini A (2003) Oxidative stress related factors in Bartter\u2019s and Gitelman\u2019s sindrome: relevance for angiotensin II signaling. Nephrol Dial Transplant 18:1518\u20131525","journal-title":"Nephrol Dial Transplant"},{"key":"249_CR15","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/hr.2011.72","volume":"34","author":"LA Cal\u00f2","year":"2011","unstructured":"Cal\u00f2 LA, Facco M, Davis PA, Pagnin E, Maso LD, Puato M, Caielli P, Agostini C, Pessina AC (2011) Endothelial progenitor cells relationships with clinical and biochemical factors in a human model of blunted angiotensin II signaling. Hypertens Res 34:1017\u20131022","journal-title":"Hypertens Res"},{"key":"249_CR16","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1097\/00004872-199816070-00014","volume":"16","author":"LA Cal\u00f2","year":"1998","unstructured":"Cal\u00f2 LA, Sartore G, Bassi A, Basso C, Bertocco S, Marin R, Zambon S, Cantaro S, D\u2019Angelo A, Davis PA, Manzato E, Crepaldi G (1998) Reduced susceptibility of low density lipoprotein to oxidation in patients with overproduction of nitric oxide (Bartter\u2019s and Gitelman\u2019s sindrome). J Hypertens 16:1001\u20131008","journal-title":"J Hypertens"},{"key":"249_CR17","first-page":"12","volume":"51","author":"L Cal\u00f2","year":"1999","unstructured":"Cal\u00f2 L, Davis PA, Milani M, Cantaro S, Antonello A, Favaro S, D\u2019Angelo A (1999) Increased endothelial nitric oxide synthase mRNA level in Bartter\u2019s and Gitelman\u2019s syndrome. Relationship to vascular reactivity. Clin Nephrol 51:12\u201317","journal-title":"Clin Nephrol"},{"key":"249_CR18","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S0272-6386(96)90514-4","volume":"27","author":"L Cal\u00f2","year":"1996","unstructured":"Cal\u00f2 L, D\u2019Angelo A, Cantaro S, Bordin MC, Favaro S, Antonello A, Borsatti A (1996) Increased urinary NO2-\/NO3- and cyclic GMP levels in patients with Bartter\u2019s syndrome: relationship to vascular reactivity. Am J Kidney Dis 27:874\u2013879","journal-title":"Am J Kidney Dis"},{"key":"249_CR19","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1093\/ndt\/gfn118","volume":"23","author":"LA Cal\u00f2","year":"2008","unstructured":"Cal\u00f2 LA, Puato M, Schiavo S, Zanardo M, Tirrito C, Pagnin E, Balbi G, Davis PA, Palatini P, Pauletto P (2008) Absence of vascular remodelling in a high angiotensin-II state (Bartter\u2019s and Gitelman\u2019s syndromes): implications for angiotensin II signalling pathways. Nephrol Dial Transplant 23:2804\u20132809","journal-title":"Nephrol Dial Transplant"},{"key":"249_CR20","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1097\/00004872-200410000-00019","volume":"22","author":"E Pagnin","year":"2004","unstructured":"Pagnin E, Davis PA, Sartori M, Semplicini A, Pessina AC, Cal\u00f2 LA (2004) Rho kinase and PAI-1 in Bartter\u2019s\/Gitelman\u2019s syndromes: relationship to angiotensin II signaling. J Hypertens 22:1963\u20131969","journal-title":"J Hypertens"},{"key":"249_CR21","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/HJH.0b013e328010d4d2","volume":"25","author":"LA Cal\u00f2","year":"2007","unstructured":"Cal\u00f2 LA, Pessina AC (2007) RhoA\/Rho-kinase pathway: much more than just a modulation of vascular tone. Evidence from studies in humans. J Hypertens 25:259\u2013264","journal-title":"J Hypertens"},{"key":"249_CR22","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1161\/01.RES.0000201960.04223.3c","volume":"98","author":"G Loirand","year":"2006","unstructured":"Loirand G, Guerin P, Pacaud P (2006) Rho kinases in cardiovascular physiology and pathophysiology. Circ Res 98:322\u2013324","journal-title":"Circ Res"},{"key":"249_CR23","doi-asserted-by":"crossref","first-page":"9472","DOI":"10.1074\/jbc.M212776200","volume":"278","author":"V Sauzeau","year":"2003","unstructured":"Sauzeau V, Rolli-Derkinderen M, Marionneau C, Loirand G, Pacaud P (2003) RhoA expression is controlled by nitric oxide through cGMP-dependent protein kinase activation. J Biol Chem 278:9472\u20139480","journal-title":"J Biol Chem"},{"key":"249_CR24","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.neulet.2006.08.038","volume":"408","author":"HG Jin","year":"2006","unstructured":"Jin HG, Yamashita H, Nagano Y, Fukuba H, Hiji M, Ohtsuki T, Takahashi T, Kohriyama T, Kaibuchi K, Matsumoto M (2006) Hypoxia-induced upregulation of endothelial small G protein RhoA and Rho-kinase\/ROCK2 inhibits eNOS expression. Neurosci Lett 408:62\u201367","journal-title":"Neurosci Lett"},{"key":"249_CR25","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1161\/01.RES.0000096650.91688.28","volume":"93","author":"M Higashi","year":"2003","unstructured":"Higashi M, Shimokawa H, Hattori T, Hiroki J, Mukai Y, Morikawa K, Ichiki T, Takahashi S, Takeshita A (2003) Long-term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo. Effect on endothelial NAD(P)H oxidase system. Circ Res 93:767\u2013775","journal-title":"Circ Res"},{"key":"249_CR26","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1161\/hy0202.103271","volume":"39","author":"C Kataoka","year":"2002","unstructured":"Kataoka C, Egashira K, Inoue S, Takemoto M, Ni W, Koyanagi M, Kitamoto S, Usui M, Kaibuchi K, Shimokawa H, Takeshita A (2002) Important role of Rho-kinase in the pathogenesis of cardiovascular inflammation and remodeling induced by long-term blockade of nitric oxide synthesis in rats. Hypertension 39:245\u2013250","journal-title":"Hypertension"},{"key":"249_CR27","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1093\/ndt\/gfl173","volume":"21","author":"E Pagnin","year":"2006","unstructured":"Pagnin E, Davis PA, Semplicini A, Cal\u00f2 LA (2006) The search for a link between inflammation and hypertension\u2014contribution from Bartter\u2019s\/Gitelman\u2019s syndromes. Nephrol Dial Transplant 21:2340\u20132342","journal-title":"Nephrol Dial Transplant"},{"key":"249_CR28","doi-asserted-by":"crossref","first-page":"H1597","DOI":"10.1152\/ajpheart.00026.2004","volume":"286","author":"JR Sowers","year":"2004","unstructured":"Sowers JR (2004) Insulin resistance and hypertension. Am J Physiol Heart Circ Physiol 286:H1597\u2013H1602","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"249_CR29","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1161\/01.ATV.0000183607.50230.9f","volume":"25","author":"T Nakakuki","year":"2005","unstructured":"Nakakuki T, Ito M, Iwasaki H, Kureishi Y, Okamoto R, Moriki N, Kongo M, Kato S, Yamada N, Isaka N, Nakano T (2005) Rho\/Rho-kinase pathway contributes to C-reactive protein-induced plasminogen activator inhibitor-1 expression in endothelial cells. Arterioscler Thromb Vasc Biol 25:2088\u20132093","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"249_CR30","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1161\/01.ATV.0000142813.33538.82","volume":"24","author":"S Wolfrum","year":"2004","unstructured":"Wolfrum S, Dendorfer A, Rikitake Y, Stalker TJ, Gong Y, Scalia R, Dominiak P, Liao JK (2004) Inhibition of Rhokinase leads to rapid activation of phosphatidylinositol 3 kinase\/protein kinase Akt and cardiovascular protection. Arterioscler Thromb Vasc Biol 24:1842\u20131847","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"249_CR31","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1242\/jcs.01118","volume":"117","author":"K Wennerberg","year":"2004","unstructured":"Wennerberg K, Der CJ (2004) Rho-family GTPases: it\u2019s not only Rac and Rho (and I like it). J Cell Sci 117:1301\u20131312","journal-title":"J Cell Sci"},{"key":"249_CR32","doi-asserted-by":"crossref","first-page":"51","DOI":"10.7150\/ijbs.1.51","volume":"1","author":"DP Siderovski","year":"2005","unstructured":"Siderovski DP, Willard FS (2005) The GAPs, GEFs, and GDIs of heterotrimeric G-protein alpha subunits. Int J Biol Sci 1:51\u201366","journal-title":"Int J Biol Sci"},{"key":"249_CR33","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.amjhyper.2004.05.006","volume":"17","author":"Z Ying","year":"2004","unstructured":"Ying Z, Jin L, Dorrance AM, Webb RC (2004) Increased expression of mRNA for regulator of G protein signaling domain-containing Rho guanine nucleotide exchange factors in aorta from stroke-prone spontaneously hypertensive rats. Am J Hypertens 17:981\u2013985","journal-title":"Am J Hypertens"},{"key":"249_CR34","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.1096\/fj.10-155499","volume":"24","author":"MC Wuertz","year":"2010","unstructured":"Wuertz MC, Lorincz A, Vettel C, Thomas MA, Wieland T, Lutz S (2010) p63RhoGEF\u2014a key mediator of angiotensin II dependent signaling and processes in vascular smooth muscle cells. FASEB J 24:4865\u20134876","journal-title":"FASEB J"},{"key":"249_CR35","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1161\/CIRCRESAHA.111.248898","volume":"109","author":"K Momotani","year":"2011","unstructured":"Momotani K, Artamonov MV, Utepbergenov D, Derewenda U, Derewenda ZS, Somlyo AV (2011) p63RhoGEF couples Gaq\/11-mediated signaling to Ca2+sensitization of vascular smooth muscle contractility. Circ Res 109:993\u20131002","journal-title":"Circ Res"},{"key":"249_CR36","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nm.2079","volume":"16","author":"C Guilluy","year":"2010","unstructured":"Guilluy C, Br\u00e9geon J, Toumaniantz G, Rolli-Derkinderen M, Retailleau K, Loufrani L, Henrion D, Scalbert E, Bril A, Torres RM, Offermanns S, Pacaud P, Loirand G (2010) The Rho exchange factor Arhgef1 mediates the effects of angiotensin II on vascular tone and blood pressure. Nat Med 16:183\u2013190","journal-title":"Nat Med"},{"key":"249_CR37","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/HJH.0000000000000075","volume":"32","author":"LA Cal\u00f2","year":"2014","unstructured":"Cal\u00f2 LA, Davis PA, Pagnin E, Dal Maso L, Maiolino G, Seccia TM, Pessina AC, Rossi GP (2014) Increased level of p63RhoGEF and RhoA\/Rho kinase activity in hypertensive patients. Implications for vascular tone regulation and cardiovascular remodeling. J Hypertens 32:331\u2013338","journal-title":"J Hypertens"},{"key":"249_CR38","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/01.ATV.0000153089.74997.02","volume":"25","author":"LA Cal\u00f2","year":"2005","unstructured":"Cal\u00f2 LA, Pagnin E, Davis PA, Sartori M, Semplicini A, Pessina AC (2005) Rho kinase inhibition and vascular protection: support from studies in Bartter and Gitelman syndrome. Arterioscler Thromb Vasc Biol 25:34\u201335","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"249_CR39","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.amjhyper.2005.03.747","volume":"18","author":"E Pagnin","year":"2005","unstructured":"Pagnin E, Semplicini A, Sartori M, Pessina AC, Cal\u00f2 LA (2005) Reduced mRNA and protein content of Rho guanine nucleotide exchange factor (RhoGEF) in Bartter\u2019s and Gitelman\u2019s syndromes: relevance for the pathophysiology of hypertension. Am J Hypertens 18:1200\u20131205","journal-title":"Am J Hypertens"},{"key":"249_CR40","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.bbadis.2010.05.002","volume":"1802","author":"A Wirth","year":"2010","unstructured":"Wirth A (2010) Rho kinase and hypertension. Biochim Biophys Acta 1802:1276\u20131284","journal-title":"Biochim Biophys Acta"},{"key":"249_CR41","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/01.hjh.0000166845.49850.39","volume":"23","author":"C Savoia","year":"2005","unstructured":"Savoia C, Tabet F, Yao G, Schiffrin EL, Touyz RM (2005) Negative regulation of RhoA\/Rho kinase by angiotensin II type 2 receptor in vascular smooth muscle cells: role in angiotensin II-induced vasodilation in stroke-prone spontaneously hypertensive rats. J Hypertens 23:1037\u20131045","journal-title":"J Hypertens"},{"key":"249_CR42","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1007\/BF03345754","volume":"32","author":"LA Cal\u00f2","year":"2009","unstructured":"Cal\u00f2 LA, Montisci R, Scognamiglio R, Davis PA, Pagnin E, Schiavo S, Mormino P, Semplicini A, Palatini P, D\u2019Angelo A, Pessina AC (2009) High angiotensin II state without cardiac remodeling (Bartter\u2019s and Gitelman\u2019s syndromes). Are angiotensin II type 2 receptors involved? J Endocrinol Invest 32:832\u2013836","journal-title":"J Endocrinol Invest"},{"key":"249_CR43","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/01.HYP.0000159192.93968.8f","volume":"45","author":"RM Carey","year":"2005","unstructured":"Carey RM (2005) Cardiovascular and renal regulation by the angiotensin type 2 receptor: the AT2 receptor comes of age. Hypertension 45:840\u2013844","journal-title":"Hypertension"},{"key":"249_CR44","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1093\/ndt\/gfl112","volume":"21","author":"PA Davis","year":"2006","unstructured":"Davis PA, Mussap M, Pagnin E, Bertipaglia L, Savica V, Semplicini A, Cal\u00f2 LA (2006) Early markers of inflammation in a high angiotensin II state. Results of studies in Bartter\u2019s\/Gitelman\u2019s syndromes. Nephrol Dial Transplant 21:1697\u20131701","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl. 82","key":"249_CR45","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1046\/j.1523-1755.62.s82.4.x","volume":"62","author":"M Ruiz-Ortega","year":"2002","unstructured":"Ruiz-Ortega M, Ruperez M, Lorenzo O, Esteban V, Blanco J, Mezzano S, Egido J (2002) Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney. Kidney Int 62(Suppl. 82):12\u201322","journal-title":"Kidney Int"},{"key":"249_CR46","first-page":"RA194","volume":"11","author":"ZJ Cheng","year":"2005","unstructured":"Cheng ZJ, Vapaatalo H, Mervaala E (2005) Angiotensin II and vascular inflammation. Med Sci Monit 11:RA194\u2013RA205","journal-title":"Med Sci Monit"},{"key":"249_CR47","first-page":"155","volume":"11","author":"UN Das","year":"2005","unstructured":"Das UN (2005) Is angiotensin II an endogenous pro-inflammatory molecule? Med Sci Monit 11:155\u2013162","journal-title":"Med Sci Monit"},{"key":"249_CR48","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1161\/01.ATV.0000183607.50230.9f","volume":"25","author":"T Nakakuki","year":"2005","unstructured":"Nakakuki T, Ito M, Iwasaki H, Kureishi Y, Okamoto R, Moriki N, Kongo M, Kato S, Yamada N, Isaka N, Nakano T (2005) Rho\/Rho-kinase pathway contributes to C-reactive protein-induced plasminogen activator inhibitor-1 expression in endothelial cells. Arterioscler Thromb Vasc Biol 25:2088\u20132093","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"249_CR49","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/S0016-5085(03)00283-X","volume":"124","author":"JP Segain","year":"2003","unstructured":"Segain JP, Raingeard de la Bletiere D, Sauzeau V, Bourreille A, Hilaret G, Cario-Toumaniantz C, Pacaud P, Galmiche JP, Loirand G (2003) Rho kinase blockade prevents inflammation via nuclear factor kappa B inhibition: evidence in Crohn\u2019s disease and experimental colitis. Gastroenterology 124:1180\u20131187","journal-title":"Gastroenterology"},{"key":"249_CR50","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/sj.jhh.1002309","volume":"22","author":"LA Cal\u00f2","year":"2008","unstructured":"Cal\u00f2 LA, Davis PA, Pagnin E, Schiavo S, Semplicini A, Pessina AC (2008) Linking inflammation and hypertension in humans: studies in Bartter\u2019s\/Gitelman\u2019s syndromes. J Hum Hypertens 22:223\u2013225","journal-title":"J Hum Hypertens"},{"key":"249_CR51","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/FJC.0b013e3182a3718f","volume":"62","author":"J Shi","year":"2013","unstructured":"Shi J, Wei L (2013) Rho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil. J Cardiovasc Pharmacol 62:341\u2013354","journal-title":"J Cardiovasc Pharmacol"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-015-0249-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-015-0249-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-015-0249-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T16:41:18Z","timestamp":1566405678000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-015-0249-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,5]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["249"],"URL":"https:\/\/doi.org\/10.1007\/s40618-015-0249-z","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,5]]}}}